John K Bakewell is Director of Xtant Medical Holdings, Inc.. Currently has a direct ownership of 755,888 shares of XTNT, which is worth approximately $400,620. The most recent transaction as insider was on Aug 15, 2024, when has been sold 162,162 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 756K
27.31% 3M change
27.31% 12M change
Total Value Held $400,620

JOHN K BAKEWELL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 15 2024
BUY
Grant, award, or other acquisition
-
162,162 Added 17.66%
755,888 Common Stock
Aug 15 2023
BUY
Grant, award, or other acquisition
-
145,180 Added 19.65%
593,726 Common Stock
Aug 15 2022
BUY
Grant, award, or other acquisition
-
215,415 Added 32.44%
448,546 Common Stock, $0.00000...
Aug 15 2021
BUY
Grant, award, or other acquisition
-
85,337 Added 26.8%
233,131 Common Stock, $0.00000...

Also insider at

TMCI
TREACE MEDICAL CONCEPTS, INC. Healthcare
STIM
Neuronetics, Inc. Healthcare
JKB

John K Bakewell

Director
Belgrade, MT

Track Institutional and Insider Activities on XTNT

Follow Xtant Medical Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XTNT shares.

Notify only if

Insider Trading

Get notified when an Xtant Medical Holdings, Inc. insider buys or sells XTNT shares.

Notify only if

News

Receive news related to Xtant Medical Holdings, Inc.

Track Activities on XTNT